PRIA Logo™
119-hr-4434119th CongressWALLET

Cosmetic Supply Chain Transparency Act of 2025

Sponsored By: Representative Schakowsky, Janice D. [D-IL-9]

Introduced

Summary

This bill would require broad _supply-chain transparency_ for cosmetics and their ingredients and create testing, reporting, and recall rules to reveal harmful contaminants.

Show full summary
  • Brand owners and retailers can request detailed ingredient and safety information from suppliers and must get it within 90 days. Required disclosures include full fragrance or flavor formulations, safety data, descending-order ingredient lists with an exception for ingredients at or below 1% by weight, and certificates of analysis.
  • Suppliers, manufacturers, formulating labs, and fragrance companies must test for nonfunctional constituents that the Food and Drug Administration lists and provide certificates of analysis before sale; testing for newly listed constituents must occur within 1 year of listing. Violations of disclosure, testing, or recall duties can trigger civil fines up to $10,000 per day.
  • The Food and Drug Administration will publish a public list of nonfunctional constituents used for testing, take 60 days for initial public comment, and finalize the initial list within 18 months while convening an advisory committee to guide testing and methods.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

3 provisions identified: 1 benefits, 0 costs, 2 mixed.

FDA list of harmful cosmetic contaminants

FDA would create a public list of harmful nonfunctional constituents in cosmetics. It would publish a proposed list, take 60 days of public comments, and finalize the first list within 18 months after enactment. An advisory group with balanced members would start within 9 months and end after the first list is final. FDA would issue testing guidance with detection limits and review the list at least yearly, with at least 30 days for public comment. Anyone could petition to add items; FDA would publish the petition steps within 24 months and decide petitions within 90 days after comments close.

States could keep stricter cosmetic rules

States would be able to ban or limit cosmetic ingredients and keep stronger reporting rules. States could continue rules they had at the time of the 2022 federal cosmetics law and this bill. If a state rule offers more transparency or protection, it could continue. Federal rules would not replace stricter state laws unless Congress clearly says so. Companies that sell in many states could face different requirements.

New cosmetic supply chain rules for businesses

This bill would set clear roles like brand owner, supplier, and manufacturer. Suppliers would need to give brand owners detailed safety and ingredient data within 90 days of a request. Finished products would need full ingredient lists in descending order, with items at 1% or less allowed at the end. Fragrance and flavor mixes would need full ingredient lists, including allergens, and IFRA certificates. When FDA adds a new nonfunctional constituent to its list, suppliers would have 1 year to test and must give a certificate of analysis before sale, including levels found, test methods, detection limits, and heavy metal results. Companies would need to keep records and share supply-chain names if FDA suspects a problem. Violations could bring civil penalties up to $10,000 per day.

Sponsors & CoSponsors

Sponsor

Schakowsky, Janice D. [D-IL-9]

IL • D

Cosponsors

  • Rep. Pingree, Chellie [D-ME-1]

    ME • D

    Sponsored 10/1/2026

  • Rep. Dingell, Debbie [D-MI-6]

    MI • D

    Sponsored 7/16/2025

  • Rep. Evans, Dwight [D-PA-3]

    PA • D

    Sponsored 7/16/2025

  • Rep. Khanna, Ro [D-CA-17]

    CA • D

    Sponsored 7/16/2025

  • Del. Norton, Eleanor Holmes [D-DC-At Large]

    DC • D

    Sponsored 7/16/2025

  • Rep. Thanedar, Shri [D-MI-13]

    MI • D

    Sponsored 7/16/2025

  • Rep. Tlaib, Rashida [D-MI-12]

    MI • D

    Sponsored 7/16/2025

  • Rep. Watson Coleman, Bonnie [D-NJ-12]

    NJ • D

    Sponsored 7/16/2025

  • Rep. Jacobs, Sara [D-CA-51]

    CA • D

    Sponsored 7/17/2025

  • Rep. Doggett, Lloyd [D-TX-37]

    TX • D

    Sponsored 7/23/2025

  • Rep. Matsui, Doris O. [D-CA-7]

    CA • D

    Sponsored 8/1/2025

  • Rep. Clarke, Yvette D. [D-NY-9]

    NY • D

    Sponsored 4/21/2026

  • Rep. Fletcher, Lizzie [D-TX-7]

    TX • D

    Sponsored 4/27/2026

  • Rep. Velázquez, Nydia M. [D-NY-7]

    NY • D

    Sponsored 7/14/2026

  • Rep. Stansbury, Melanie A. [D-NM-1]

    NM • D

    Sponsored 9/15/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation